Through the comparison between symptoms and inflammatory indexes, we found that dyspnea and fever were correlated with some indexes, such as lymphocyte count, CRP and inflammatory cytokines, which could suggest us to take measures in these patients with dyspnea or fever at the early stage of COVID-19 and that these patients symptom severity might be more severe than those without dyspnea or fever. The gene discussed is CRP; the disease is COVID-19.